Risk Factors and Treatment Options for Failure of a Two-Stage Exchange

[1]  D. Albala,et al.  Management of , 2018, Basic Urological Management.

[2]  D. Berry,et al.  Periprosthetic Joint Infection With Fungal Pathogens. , 2018, The Journal of arthroplasty.

[3]  A. Rajgopal,et al.  Does Prior Failed Debridement Compromise the Outcome of Subsequent Two-Stage Revision Done for Periprosthetic Joint Infection Following Total Knee Arthroplasty? , 2018, The Journal of arthroplasty.

[4]  J. Parvizi,et al.  All Patients Should Be Screened for Diabetes Before Total Joint Arthroplasty. , 2018, The Journal of arthroplasty.

[5]  J. Ko,et al.  Predictors of Treatment Failure Following Two-stage Reimplantation for 1 Infected Total Knee Arthroplasty : a 2 − 10 Years Follow-up 2 , 2018 .

[6]  K. Søballe,et al.  Patient-reported quality of life and hip function after 2-stage revision of chronic periprosthetic hip joint infection: a cross-sectional study , 2018, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[7]  J. Parvizi,et al.  Time to Reimplantation: Waiting Longer Confers No Added Benefit. , 2018, The Journal of arthroplasty.

[8]  J. Parvizi,et al.  Changes in Antibiotic Susceptibility of Staphylococcus aureus Between the Stages of 2-Stage Revision Arthroplasty. , 2018, The Journal of arthroplasty.

[9]  P. Boisrenoult.  Cutibacterium acnes prosthetic joint infection: Diagnosis and treatment. , 2017, Orthopaedics & traumatology, surgery & research : OTSR.

[10]  Benjamin A Lipsky,et al.  Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  W. Novicoff,et al.  Removal of an Infected Hip Arthroplasty Is a High-Risk Surgery: Putting Morbidity Into Context With Other Major Nonorthopedic Operations. , 2017, The Journal of arthroplasty.

[12]  J. Cancienne,et al.  Removal of an Infected Total Hip Arthroplasty: Risk Factors for Repeat Debridement, Long-term Spacer Retention, and Mortality. , 2017, The Journal of arthroplasty.

[13]  V. Prendki,et al.  Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  D. Schroeder,et al.  Association Between Smoking Status, Preoperative Exhaled Carbon Monoxide Levels, and Postoperative Surgical Site Infection in Patients Undergoing Elective Surgery , 2017, JAMA surgery.

[15]  C. Perka,et al.  High failure rates in treatment of streptococcal periprosthetic joint infection: RESULTS FROM A SEVEN‐YEAR RETROSPECTIVE COHORT STUDY , 2017, The bone & joint journal.

[16]  J. Jauregui,et al.  Hip fusion takedown to a total hip arthroplasty—is it worth it? A systematic review , 2017, International Orthopaedics.

[17]  U. Lenze,et al.  Prosthetic joint infection development of an evidence-based diagnostic algorithm , 2017, European Journal of Medical Research.

[18]  J. Parvizi,et al.  Periprosthetic Joint Infections Caused by Enterococci Have Poor Outcomes. , 2017, The Journal of arthroplasty.

[19]  Á. Soriano,et al.  Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention-authors' response. , 2016, Journal of Antimicrobial Chemotherapy.

[20]  Á. Soriano,et al.  Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  M. Beilke,et al.  Prolonged oral antibiotic suppression in osteomyelitis and associated outcomes in a Veterans population. , 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[22]  W. Barsoum,et al.  Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship. , 2015, The Journal of bone and joint surgery. American volume.

[23]  Qi Zhang,et al.  Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. , 2015, The Journal of hospital infection.

[24]  E. Garcia-Rey,et al.  Clinical outcome following conversion of Girdlestone's resection arthroplasty to total hip replacement: a retrospective matched case-control study. , 2014, The bone & joint journal.

[25]  Á. Soriano,et al.  Risk Factors for Failure in Early Prosthetic Joint Infection Treated with Debridement. Influence of Etiology and Antibiotic Treatment , 2014, Journal of applied biomaterials & functional materials.

[26]  Robin Patel,et al.  Prosthetic Joint Infection , 2014, Clinical Microbiology Reviews.

[27]  Paul T. H. Lee,et al.  Antibiotic treatment and timing of reimplantation. , 2014, The Journal of arthroplasty.

[28]  J. Parvizi,et al.  Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection , 2014 .

[29]  Parvizi Javad,et al.  Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection , 2014 .

[30]  J. Parvizi,et al.  Recurrent periprosthetic joint infection: persistent or new infection? , 2013, The Journal of arthroplasty.

[31]  J. Chang,et al.  Effect of culture media and nutrients on biofilm growth kinetics of laboratory and clinical strains of Enterococcus faecalis. , 2013, Archives of oral biology.

[32]  Á. Soriano,et al.  A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  B. Espehaug,et al.  Infection after primary hip arthroplasty A comparison of 3 Norwegian health registers , 2013 .

[34]  S. Yeo,et al.  Two-year outcome of early deep MRSA infections after primary total knee arthroplasty: a joint registry review. , 2013, The Journal of arthroplasty.

[35]  Heather N. Watson,et al.  Economic burden of periprosthetic joint infection in the United States. , 2012, The Journal of arthroplasty.

[36]  A. Eskelinen,et al.  Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. , 2012, The Journal of bone and joint surgery. American volume.

[37]  L. Sørensen.  Wound Healing and Infection in Surgery: The Pathophysiological Impact of Smoking, Smoking Cessation, and Nicotine Replacement Therapy A Systematic Review , 2012, Annals of surgery.

[38]  K. Søballe,et al.  Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis , 2012, Clinical epidemiology.

[39]  M. Hawn,et al.  The Attributable Risk of Smoking on Surgical Complications , 2011, Annals of surgery.

[40]  B. Espehaug,et al.  Infection after primary hip arthroplasty , 2011, Acta orthopaedica.

[41]  L. Engesæter,et al.  Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register , 2011, Acta orthopaedica.

[42]  J. Parvizi,et al.  New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection Society , 2011, Clinical orthopaedics and related research.

[43]  A. Murcia-Mazón,et al.  Is Total Hip Arthroplasty after Hip Arthrodesis as Good as Primary Arthroplasty? , 2011, Clinical orthopaedics and related research.

[44]  Á. Soriano,et al.  Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[45]  S. Odum,et al.  The Chitranjan Ranawat Award: Fate of Two-stage Reimplantation After Failed Irrigation and Débridement for Periprosthetic Knee Infection , 2011, Clinical orthopaedics and related research.

[46]  K. Peck,et al.  Risk factors for treatment failure in patients with prosthetic joint infections. , 2010, The Journal of hospital infection.

[47]  I. Sia,et al.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[48]  Elhadi Sariali,et al.  Total hip arthroplasty revision due to infection: a cost analysis approach. , 2010, Orthopaedics & traumatology, surgery & research : OTSR.

[49]  G. Forrest,et al.  Rifampin Combination Therapy for Nonmycobacterial Infections , 2010, Clinical Microbiology Reviews.

[50]  P. Bejon,et al.  One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome , 2009, The Journal of antimicrobial chemotherapy.

[51]  P. Choong,et al.  Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[52]  Khaled J Saleh,et al.  Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. , 2007, The Journal of bone and joint surgery. American volume.

[53]  L. Aguilar,et al.  Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. , 2006, The American journal of medicine.

[54]  W. Zimmerli,et al.  Management of Infection Associated with Total Hip Arthroplasty according to a Treatment Algorithm , 2004, Infection.

[55]  W. Hozack,et al.  Complications Associated With Reimplantation After Girdlestone Arthroplasty , 2003, Clinical orthopaedics and related research.

[56]  J. Rand,et al.  Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. , 1999, Instructional course lectures.

[57]  C. A. Peterson,et al.  Tibia-Hindfoot Osteomusculocutaneous Rotationplasty with Calcaneopelvic Arthrodesis for Extensive Loss of Bone from the Proximal Part of the Femur. A Report of Two Cases* , 1997, The Journal of bone and joint surgery. American volume.

[58]  A. Hanssen,et al.  Infection after total hip arthroplasty. Past, present, and future. , 1995, The Journal of bone and joint surgery. American volume.

[59]  J. Kostuik,et al.  Arthrodesis for Failed Arthroplasty of the Hip , 1984, Clinical orthopaedics and related research.

[60]  H W Buchholz,et al.  Management of deep infection of total hip replacement. , 1981, The Journal of bone and joint surgery. British volume.

[61]  E. Engelbrecht,et al.  Disarticulation of the hip as a result of failed arthroplasty. A series of 11 cases. , 1980, The Journal of bone and joint surgery. British volume.

[62]  J. Clegg.  The results of the pseudarthrosis after removal of an infected total hip prosthesis. , 1977, The Journal of bone and joint surgery. British volume.

[63]  P. D. Wilson,et al.  Total hip replacement with fixation by acrylic cement. A preliminary study of 100 consecutive McKee-Farrar prosthetic replacements. , 1972, The Journal of bone and joint surgery. American volume.

[64]  F. P. Patterson,et al.  The McKee-Farrar total hip replacement. Preliminary results and complications of 368 operations performed in five general hospitals. , 1972, The Journal of bone and joint surgery. American volume.

[65]  R. Taylor.  Pseudarthrosis of the Hip-joint. , 1950, Proceedings of the Royal Society of Medicine.